IMIWN - Official Launch 16th June 2025 at BIO 2025, Boston, Massachusetts

We are pleased to announce that we will be launching our sTLR2 RAPID 10 minute test for sepsis and inflammation, as well as our portfolio of proprietary anti-sTLR2 monoclonal and polyclonal antibodies, at the BIO International Convention 2025 in Boston, Massachusetts.

Opportunities for licensing and distribution of our rapid sepsis test and antibody panel will be available. 

We would be delighted if you could join our CEO on the Welsh Government stand booth 695, from the 16th to the 19th of June 2025, to learn more about these exciting opportunities in the sepsis and inflammatory diagnostics sector.

UK Patent Application GB2502531.3.